Association between computed tomography‐assessed sarcopenia and mortality in patients with anti‐neutrophil cytoplasmic antibody‐associated vasculitis
International Journal of Rheumatic Diseases · 2023-09 · 26 (9) · 1704-1713
DOI: 10.1111/1756-185x.14795 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 23.06.2023. Verfasst von Sung Soo Ahn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea. Hauptthemen laut MEDLINE: Sarcopenia, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: CELLTRION PHARM, Inc., Handok Inc., Korea Health Industry Development Institute.
Abstract (Originalsprache)
Aim
Sarcopenia is frequently observed in patients with autoimmune rheumatic diseases; however, its relationship with patient outcomes has not been well understood. This study evaluated the influence of sarcopenia, especially muscle quality, on outcomes of antineutrophil cytoplasmic antibody‐associated vasculitis (AAV).
Methods
Records of patients with AAV at the Severance Hospital with computed tomography (CT) images taken at initial disease diagnosis were retrospectively reviewed. For measures of sarcopenia, normal attenuation muscle area (NAMA), low attenuation muscle area (LAMA), intramuscular adipose tissue (IMAT), and total abdominal muscle area (TAMA) in the axial muscles of the middle third lumbar vertebra level were calculated. Correlations between NAMA, LAMA, IMAT, and baseline patient characteristics, as well as the association between the NAMA/TAMA ratio and clinical outcomes were assessed.
Results
A total of 136 patients with CT images at AAV diagnosis were identified. Correlation analyses revealed that age, female sex, total cholesterol, and alanine aminotransferase were significantly associated with NAMA. LAMA was associated with age, body mass index (BMI), five‐factor score (FFS), and C‐reactive protein, and a relationship between IMAT and age and BMI was observed. During the follow up of 31.2 months, 23 (16.9%) patients died, and Cox‐proportional hazard analysis demonstrated that a NAMA/TAMA ≤0.46 (odds ratio [OR] 10.247, p < .001), female sex (OR 0.206, p = .006), dyslipidemia (OR 3.143, p = .027), creatinine (OR 1.342, p = .012), and FFS (OR 1.775, p = .046), were independently associated with patient mortality.
Conclusion
A higher rate of mortality was observed in patients with AAV with NAMA/TAMA ≤0.46, indicating that careful monitoring is required in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
- Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea.
ORCID-Profile: Sung Soo Ahn, Yong-Beom Park, Sang-Won Lee
Förderung
- CELLTRION PHARM, Inc.
- Handok Inc.
- Korea Health Industry Development Institute
Zitieren
APA
Ahn, S. S., Park, Y. B., & Lee, S. W. (2023). Association between computed tomography‐assessed sarcopenia and mortality in patients with anti‐neutrophil cytoplasmic antibody‐associated vasculitis. International Journal of Rheumatic Diseases, 26(9), 1704-1713. https://doi.org/10.1111/1756-185x.14795
Vancouver
Ahn SS, Park YB, Lee SW. Association between computed tomography‐assessed sarcopenia and mortality in patients with anti‐neutrophil cytoplasmic antibody‐associated vasculitis. International Journal of Rheumatic Diseases. 2023;26(9):1704-1713. doi:10.1111/1756-185x.14795
BibTeX
@article{Ahn2023,
author = {Ahn, Sung Soo and Park, Yong-Beom and Lee, Sang-Won},
title = {Association between computed tomography‐assessed sarcopenia and mortality in patients with anti‐neutrophil cytoplasmic antibody‐associated vasculitis},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
volume = {26},
number = {9},
pages = {1704--1713},
doi = {10.1111/1756-185x.14795}
}
EUVIMED